The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cells

被引:11
|
作者
Dar, Javid A. [1 ,4 ]
Masoodi, Khalid Z. [1 ]
Eisermann, Kurtis [1 ]
Isharwal, Sudhir [1 ]
Ai, Junkui [1 ]
Pascal, Laura E. [1 ]
Nelson, Joel B. [1 ,3 ]
Wang, Zhou [1 ,2 ,3 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15232 USA
[2] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15232 USA
[4] King Saud Univ, Coll Sci, Cent Lab, Riyadh Ksa 11451, Saudi Arabia
基金
美国国家卫生研究院;
关键词
AMINO-ACID SUBSTITUTIONS; DNA-BINDING DOMAIN; TRANSCRIPTIONAL ACTIVATION; TRANSACTIVATION DOMAIN; INSENSITIVITY SYNDROME; COMPLEMENTARY-DNA; HSP90; INHIBITOR; LIGAND; MUTATION; IDENTIFICATION;
D O I
10.1016/j.jsbmb.2014.03.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Androgen-independent nuclear localization is required for androgen receptor (AR) transactivation in castration-resistant prostate cancer (CRPC) and should be a key step leading to castration resistance. However, mechanism(s) leading to androgen-independent AR nuclear localization are poorly understood. Since the N-terminal domain (NTD) of AR plays a role in transactivation under androgen-depleted conditions, we investigated the role of the NTD in AR nuclear localization in CRPC. Deletion mutagenesis was used to identify amino acid sequences in the NTD essential for its androgen-independent nuclear localization in C4-2, a widely used CRPC cell line. Deletion mutants of AR tagged with green fluorescent protein (GFP) at the 5'-end were generated and their signal distribution was investigated in C4-2 cells by fluorescent microscopy. Our results showed that the region of a.a. 294-556 was required for androgen-independent AR nuclear localization whereas a.a. 1-293 mediates Hsp90 regulation of AR nuclear localization in CRPC cells. Although the region of a.a. 294-556 does not contain a nuclear import signal, it was able to enhance DHT-induced import of the ligand binding domain (LBD). Also, transactivation of the NTD could be uncoupled from its modulation of AR nuclear localization in C4-2 cells. These observations suggest an important role of the NTD in AR intracellular trafficking and androgen-independent AR nuclear localization in CRPC cells. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:473 / 480
页数:8
相关论文
共 50 条
  • [1] Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain
    Peng, Shihong
    Wang, Jie
    Chen, Huang
    Hu, Pan
    He, Xiao-Long
    He, Yundong
    Wang, Minna
    Tang, Wenshu
    He, Qiurui
    Wang, Ying-Ying
    Xie, Jiayi
    Guo, Dandan
    Ren, Shancheng
    Liu, Mingyao
    Qiu, Wen-Wei
    Yi, Zhengfang
    CELL BIOLOGY AND TOXICOLOGY, 2020, 36 (05) : 399 - 416
  • [2] Discovery of a Small-Molecule Inhibitor Targeting the Androgen Receptor N-Terminal Domain for Castration-Resistant Prostate Cancer
    Yi, Qianhui
    Liu, Weiguo
    Seo, Jung Hwa
    Su, Jie
    Alaoui-Jamali, Moulay A.
    Luo, Jun
    Lin, Rongtuan
    Wu, Jian Hui
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (05) : 570 - 582
  • [3] Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer
    Ban, Fuqiang
    Leblanc, Eric
    Cavga, Ayse Derya
    Huang, Chia-Chi Flora
    Flory, Mark R.
    Zhang, Fan
    Chang, Matthew E. K.
    Morin, Helene
    Lallous, Nada
    Singh, Kriti
    Gleave, Martin E.
    Mohammed, Hisham
    Rennie, Paul S.
    Lack, Nathan A.
    Cherkasov, Artem
    CANCERS, 2021, 13 (14)
  • [4] Inhibiting androgen receptor nuclear entry in castration-resistant prostate cancer
    Pollock, Julie A.
    Wardell, Suzanne E.
    Parent, Alexander A.
    Stagg, David B.
    Ellison, Stephanie J.
    Alley, Holly M.
    Chao, Christina A.
    Lawrence, Scott A.
    Stice, James P.
    Spasojevic, Ivan
    Baker, Jennifer G.
    Kim, Sung Hoon
    McDonnell, Donald P.
    Katzenellenbogen, John A.
    Norris, John D.
    NATURE CHEMICAL BIOLOGY, 2016, 12 (10) : 795 - +
  • [5] An androgen receptor N-terminal domain antagonist for treating prostate cancer
    Myung, Jae-Kyung
    Banuelos, Carmen A.
    Fernandez, Javier Garcia
    Mawji, Nasrin R.
    Wang, Jun
    Tien, Amy H.
    Yang, Yu Chi
    Tavakoli, Iran
    Haile, Simon
    Watt, Kate
    McEwan, Iain J.
    Plymate, Stephen
    Andersen, Raymond J.
    Sadar, Marianne D.
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (07) : 2948 - 2960
  • [6] Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence
    Coutinho, Isabel
    Day, Tanya K.
    Tilley, Wayne D.
    Selth, Luke A.
    ENDOCRINE-RELATED CANCER, 2016, 23 (12) : T179 - T197
  • [7] Androgen receptor (AR) aberrations in castration-resistant prostate cancer
    Waltering, Kati K.
    Urbanucci, Alfonso
    Visakorpi, Tapio
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 360 (1-2) : 38 - 43
  • [8] Androgen Receptor and Beyond, Targeting Androgen Signaling in Castration-Resistant Prostate Cancer
    Reichert, Zachery R.
    Hussain, Maha
    CANCER JOURNAL, 2016, 22 (05) : 326 - 329
  • [9] Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic
    Imamura, Yusuke
    Sadar, Marianne D.
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (08) : 654 - 665
  • [10] ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
    Wang, Junjian
    Zou, June X.
    Xue, Xiaoqian
    Cai, Demin
    Zhang, Yan
    Duan, Zhijian
    Xiang, Qiuping
    Yang, Joy C.
    Louie, Maggie C.
    Borowsky, Alexander D.
    Gao, Allen C.
    Evans, Christopher P.
    Lam, Kit S.
    Xu, Jianzhen
    Kung, Hsing-Jien
    Evans, Ronald M.
    Xu, Yong
    Chen, Hong-Wu
    NATURE MEDICINE, 2016, 22 (05) : 488 - 496